Hiroko Chimori

Study Protocol for the Initial Choice of DPP-4 Inhibitor in Japanese Patients with Type 2 diabetes Mellitus: Effect of Linagliptin on QOL (INTEL-QOL) Trial

H. Watada, T. Mita, T. Hiyoshi, 2018, Diabetes Therapy.

The Effect of Linagliptin versus Metformin Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus

H. Watada, Y. Kojima, M. Shimizu, 2018, Diabetes Therapy.

Effects of linagliptin monotherapy compared with voglibose on postprandial lipid profiles in Japanese patients with type 2 diabetes: linagliptin study of effects on postprandial blood glucose (L-STEP) sub-study 1.

H. Watada, M. Gosho, I. Inoue, 2018, Endocrine journal.

Protective Effect of Maternal Influenza Vaccination on Influenza in Their Infants: A Prospective Cohort Study

Y. Shiki, Y. Ishikawa, M. Nishikawa, 2017, The Journal of infectious diseases.

Overall Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Versus Dipeptidyl-Peptidase 4 Inhibitors: Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT study)

T. Nishikawa, T. Katsuya, T. Matsuda, 2023, Diabetes Therapy.